No Data
No Data
H.C. Wainwright Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $12
Promising Clinical Outcomes and Revenue Growth Drive Buy Rating for Sensus Healthcare
Declining Stock and Solid Fundamentals: Is The Market Wrong About Sensus Healthcare, Inc. (NASDAQ:SRTS)?
Here's Why Sensus Healthcare, Inc. (SRTS) Gained But Lagged the Market Today
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Sensus Healthcare to Participate in the 37th Annual ROTH Conference